Scientific and regulatory evaluation of empirical pharmacometric models: An application of the risk informed credibility assessment framework
Abstract Empirical pharmacometric models are part of practically every regulatory submission for a new drug. The use of the models often exceeds descriptory roles and this change in their context of use increase the requirements on the evidence to support that they are credible. However, when it com...
Guardado en:
Autores principales: | Ine Skottheim Rusten, Flora Tshinanu Musuamba |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/22f9226774ba4d07af13a0fb0501d239 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility
por: Flora T. Musuamba, et al.
Publicado: (2021) -
Metaheuristics for pharmacometrics
por: Seongho Kim, et al.
Publicado: (2021) -
Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy
por: Michael A. Tortorici, et al.
Publicado: (2021) -
Pharmacometric analyses of alectinib to facilitate approval of the optimal dose for the first‐line treatment of anaplastic lymphoma kinase–positive non‐small cell lung cancer
por: Joy C. Hsu, et al.
Publicado: (2021) -
Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
por: Rena Eudy‐Byrne, et al.
Publicado: (2021)